Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITRATION: Tecfidera Dosing Strategy in MS
NCT02428231Phase 3Terminated
- Sponsor
- Biogen
- Start
- Apr 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Biogen. Started Apr 2015; status: terminated.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02428231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428231.